发明名称 |
MODULATION OF SYSTEMIC EXPOSURE TO RIFAXIMIN |
摘要 |
The present invention relates to the effect of hepatic insufficiency on the pharmacokinetics of rifaximin. Also provided are methods of determining an appropriate dose of rifaximin for a subject suffering from hepatic insufficiency. In addition, methods of treatment are provided subjects having or susceptible to hepatic insufficiency to be treated with rifaximin. |
申请公布号 |
KR20120030542(A) |
申请公布日期 |
2012.03.28 |
申请号 |
KR20127001128 |
申请日期 |
2010.06.15 |
申请人 |
SALIX PHARMACEUTICALS, LTD. |
发明人 |
FORBES WILLIAM |
分类号 |
A61K31/44;A61K31/397;A61K31/437;A61P1/16 |
主分类号 |
A61K31/44 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|